(Q33500185)

English

Statins and total (not LDL) cholesterol concentration and outcome of myocardial infarction: results from a meta-analysis and an observational study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

0 references

1 reference

Europe PubMed Central

Statins and total (not LDL) cholesterol concentration and outcome of myocardial infarction: results from a meta-analysis and an observational study (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

author name string

Xia Sheng

1

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Li Wei

2

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Michael J Murphy

3

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Thomas M MacDonald

4

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

publication date

1 November 2009

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

European Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

65

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

1071-1080

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

https://scigraph.springernature.com/pub.10.1007/s00228-009-0720-x

0 references

Relationship between plasma LDL concentrations during treatment with pravastatin and recurrent coronary events in the Cholesterol and Recurrent Events trial.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-009-0720-X

21 January 2018

Long-term effects of cholesterol lowering and angiotensin-converting enzyme inhibition on coronary atherosclerosis: The Simvastatin/Enalapril Coronary Atherosclerosis Trial (SCAT).

1 reference

https://api.crossref.org/works/10.1007%2FS00228-009-0720-X

21 January 2018

Coronary angiographic changes with lovastatin therapy. The Monitored Atherosclerosis Regression Study (MARS).

1 reference

https://api.crossref.org/works/10.1007%2FS00228-009-0720-X

21 January 2018

Effects of cigarette smoking on the angiographic evolution of coronary atherosclerosis. A Canadian Coronary Atherosclerosis Intervention Trial (CCAIT) Substudy. CCAIT Study Group.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-009-0720-X

21 January 2018

Kuopio Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-009-0720-X

21 January 2018

The effect of simvastatin on progression of coronary artery disease. The Multicenter coronary Intervention Study (CIS).

1 reference

https://api.crossref.org/works/10.1007%2FS00228-009-0720-X

21 January 2018

Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/19730842

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/19730842

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. 1995.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19730842

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19730842

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

'Real-life' reduction in cholesterol with statins, 1993 to 2002.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19730842

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://pubmed.ncbi.nlm.nih.gov/19730842

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): Reduction in atherosclerosis progression and clinical events

1 reference

https://pubmed.ncbi.nlm.nih.gov/19730842

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19730842

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/19730842

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS)

1 reference

https://pubmed.ncbi.nlm.nih.gov/19730842

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of statins in primary and secondary prevention of coronary heart disease and ischemic stroke. Meta-analysis of randomized trials.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19730842

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19730842

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Traditional reviews, meta-analyses and pooled analyses in epidemiology

1 reference

https://pubmed.ncbi.nlm.nih.gov/19730842

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

1 reference

https://pubmed.ncbi.nlm.nih.gov/19730842

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of fluvastatin on cardiac events in patients with symptomatic coronary artery disease during one year of treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/19730842

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

1 reference

https://pubmed.ncbi.nlm.nih.gov/19730842

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/19730842

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of fluvastatin on coronary atherosclerosis in patients with mild to moderate cholesterol elevations (Lipoprotein and Coronary Atherosclerosis Study [LCAS])

1 reference

https://pubmed.ncbi.nlm.nih.gov/19730842

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of pravastatin in patients with serum total cholesterol levels from 5.2 to 7.8 mmol/liter (200 to 300 mg/dl) plus two additional atherosclerotic risk factors. The Pravastatin Multinational Study Group for Cardiac Risk Patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19730842

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS)

1 reference

https://pubmed.ncbi.nlm.nih.gov/19730842

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19730842

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19730842

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Can change in high-density lipoprotein cholesterol levels reduce cardiovascular risk?

1 reference

https://pubmed.ncbi.nlm.nih.gov/19730842

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19730842

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of pravastatin (10 mg/day) on progression of coronary atherosclerosis in patients with serum total cholesterol levels from 160 to 220 mg/dl and angiographically documented coronary artery disease. Coronary Artery Regression Study (CARS) Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/19730842

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

1 reference

https://pubmed.ncbi.nlm.nih.gov/19730842

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries (PLAC-II)

1 reference

https://pubmed.ncbi.nlm.nih.gov/19730842

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Statin use in the secondary prevention of coronary heart disease in primary care: cohort study and comparison of inclusion and outcome with patients in randomised trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/19730842

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00228-009-0720-X

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33500185&oldid=1618623969"